Citi Pharma Gets CCP Approval to Acquire Pakheim International Pharma

Citi Pharma Limited has received regulatory approval to acquire the entire shareholding of Pakheim International Pharma (Private) Limited, bringing the proposed transaction a step closer to completion.

Key points

• After the commission's review of the transaction, the approval was granted under Section 31(1)(d)(I) of the Competition Act, 2010.
• The proposed accord involves the acquisition of 100% of Pakheim International Pharma's shareholding.
• The firm went on that it would create further disclosures as required once the transaction reaches the relevant milestones.
• Obtain the latest business news, market insights, and economic updates wherever you prefer.

In a material information notice dated October 16, 2026, submitted to the Pakistan Stock Exchange (PSX), Citi Pharma remarked the Competition Commission of Pakistan (CCP) issued its order on October 9, 2026, authorizing the proposed acquisition.

After the commission's review of the transaction, the approval was granted under Section 31(1)(d)(I) of the Competition Act, 2010. According to the company's disclosure, the CCP determined that the proposed acquisition did not raise competition reservations. Chinese IPPs Demand Rs. 498 Billion in Unpaid Dues.

Citi Pharma remarked the acquisition would proceed in accordance with the terms of a share purchase agreement signed on May 6, 2026, subject to the completion of applicable legal, regulatory and other formalities.

Meanwhile, the firm went on that it would create further disclosures as required once the transaction reaches the relevant milestones.

Notably, the proposed accord involves the acquisition of 100% of Pakheim International Pharma's shareholding. Nevertheless, Citi Pharma's disclosure did not specify the transaction value or provide further details concerning the projected financial impact of the acquisition. Stay Connected with ProPakistani.

Obtain the latest business news, market insights, and economic updates wherever you prefer. Follow on Google Discover. Follow on Google News Join WhatsApp. See more ProPakistani stories in Google Search and Top Stories.

For now, citi Pharma Gets CCP Approval to Acquire Pakheim International Pharma remains the part of the story worth watching, and further updates are likely as more details are confirmed.